|
01-31-2012, 03:26 PM
|
|||
|
|||
FDA Approves Skin Cancer Drug for 'Major Advances in Treatment'
The U.S. Food and Drug Administration on Monday gave a green light to a basal cell skin cancer drug made by Roche Holding AG and Curis Inc. The drug will be marketed by Roche's San Francisco-based Genetech arm under the brand name Erivedge.
    
|
 |
| Thread Tools | |
| Display Modes | |
|
|
Linear Mode
